Stellar is a manufacturer of KLH, an immune-stimulating protein widely used as a carrier molecule in the development of immunotherapies. Spain-based Araclon is majority-owned by global healthcare firm
Under the deal, Takeda will use GE’s diagnostic imaging technology to noninvasively map the hardening of liver tissue. Combining the strengths of the two companies, the collaboration is
The two firms aim to exploit business opportunities in the Chinese market for new drugs. Under the deal, ScinoPharm will be responsible for the development and manufacturing of
Selinexor works by inhibiting the nuclear export protein XPO1, leading to the accumulation of tumor suppressor proteins in the cell nucleus, which subsequently reinitiates and amplifies their tumor
A new recombinant FVIII, Nuwiq is produced in a human cell line cultured without additives of human or animal origin or any exposure to human blood or plasma,
Trulicity comes in a single-dose pen and does not require the patient to mix, measure, or handle the needle and it is not recommended as first-line therapy for
With the exclusive license, Pharco will now be able to expand its licensed territory to one or more additional countries in the Middle East and North Africa (MENA)
Evolocumab inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver’s ability to remove low-density lipoprotein cholesterol (LDL-C) or bad cholesterol from the blood. The
DCV is a fixed-dose combination of daclatasvir 30mg with asunaprevir 200mg (ASV) and beclabuvir 75mg (BCV). Primary endpoint for the two trials was the percentage of patients who
Alios, which is focused on developing therapies for viral diseases, will now be part of the infectious diseases therapeutic area of the Janssen Pharmaceutical Companies of J&J. The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.